The highly anticipated "Pharmbudget 2025" Conference took place today, marking a significant event for the pharmaceutical community. This flagship gathering brought together company executives, importers, distributors, and pharmacy chains to gain insights into the industry's prospects for the coming year.
Dmytro Aleshko, managing partner of LA Law Firm, and Yevhenia Lukyanchuk, head of "APTEKA.ua Weekly," moderated a panel discussion on the critical dialogue between government authorities, regulatory bodies, and the pharmaceutical industry. Joined by representatives from the Ministry of Health of Ukraine, the American Chamber of Commerce in Ukraine, the European Business Association, and leading pharmaceutical companies, the panelists discussed emerging regulations and initiatives that could shape the industry's future.
Parallel imports and product labeling for medicines were among the primary issues debated at the panel discussion.
The event focused on the transformation of Ukraine's intellectual property sector on its path toward European integration.
Improving access to safe and affordable medicines for the Ukrainian population is one of the Government of Ukraine's top priorities. SAFEMed Activity (2017-2025) has supported this effort by appIying health system strengthening best practices.
The Ministry of Health website has posted a notice about the release of a revised draft order of the Ministry of Health ‘On Approval of Amendments to Certain Re
On 25 September, a webinar was held on the topic: ‘180 days of new drug price regulation. Results, prospects and practical advice.’ The event was organized by LA Law Firm in partnership with Proxima Research International.
